Unique product.24 Nov 2022 09:41
"By classifying ScanNav Anatomy Peripheral Nerve Block (PNB) under its de novo programme, the FDA has concluded that there are no devices already on the market which meet the same clinical need. It has therefore created the new generic type of device classification of real-time anatomy visualization and labelling device for ultrasound guided regional anaesthesia."
£10m expected revenue this year, targeted £25m for 2025, cash in bank, potential new products to market place. £24m Mcap. A buy IMHO.